Association between phosphate removal and markers of bone turnover in haemodialysis patients

被引:27
作者
Albalate, Marta
de la Piedra, Concepcion
Fernandez, Cristina
Lefort, Mar
Santana, Henar
Hernando, Paloma
Hernandez, Jesus
Caramelo, Carlos
机构
[1] Univ Autonoma Madrid, Hosp Clin, Serv Nefrol & Bioquim, Fdn Jimenez Diaz, Madrid, Spain
[2] Univ Autonoma Madrid, Hosp Clin, Serv Epidemiol, Madrid, Spain
[3] Univ Complutense Madrid, Madrid, Spain
关键词
bone turnover; haemodialysis; osteoprotegerin; phosphate removal; PTH; RANKL;
D O I
10.1093/ndt/gfl034
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. As the main mineral reservoir, bone acts as a calcium (Ca) and phosphate buffering system. Accordingly, phosphate removal by haemodialysis (HD) might be theoretically influenced by bone turnover, as well as by the interaction of regulatory molecules, such as PTH and osteoprotegerin (OPG). The present study investigated the relationship between these variables and phosphate removal by HD. Methods. Blood samples for serum Ca, phosphate, bicarbonate, intact PTH, PTH (1 - 84), bone alkaline phosphatase, tartrate-resistant acid phosphatase 5b, OPG and receptor activator of nuclear factor-kappa B ligand ( RANKL) were obtained in 28 HD patients. Phosphate removal was measured by a continuous collection of the dialysate. Results. Pre-dialysis serum phosphate concentration is the critical factor in determining dialytic phosphate removal. However, multiple regression analysis reveals that phosphate removal is better explained by a combination of factors than by phosphate concentration alone. In this model, the PTH/OPG ratio is an additional positive factor, whereas age and vitamin D treatment are negative factors. Patients with pre-HD bicarbonate higher than 20 mEq/l had higher serum phosphate and, accordingly, higher phosphate removal; of interest, these individuals also have significant differences in RANKL/OPG. Mean (SD) OPG levels were significantly higher than that in the healthy population (16.2 ( 12.5) pmol/ l; these values correlated with age (r = 0.4, P < 0.04). Mean serum RANKL (1.03 (1.02) pmol/l) was within the range of normal individuals. Conclusions. Dialytic phosphate removal has a crucial, direct relationship with pre-HD plasma phosphate levels. However, the phenomenon of phosphate removal is more precisely explained using a more complex relationship, defined by the interaction between serum phosphate, PTH/ OPG, age and vitamin D administration. Serum RANKL levels are first reported in HD patients, and are not different from the normal population.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 19 条
  • [1] Albalate M, 2003, NEFROLOGIA, V23, P520
  • [2] Increased levels of osteoprotegerin in hemodialysis patients
    Avbersek-Luznik, I
    Malesic, I
    Rus, I
    Marc, J
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (10) : 1019 - 1023
  • [3] METABOLIC-ACIDOSIS IS A POTENT STIMULUS FOR CELLULAR INORGANIC-PHOSPHATE GENERATION IN UREMIA
    BEVINGTON, A
    BROUGH, D
    BAKER, FE
    HATTERSLEY, J
    WALLS, J
    [J]. CLINICAL SCIENCE, 1995, 88 (04) : 405 - 412
  • [4] Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
    Block, GA
    Hulbert-Shearon, TE
    Levin, NW
    Port, FK
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) : 607 - 617
  • [5] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [6] Serum osteoprotegerin and renal osteodystrophy
    Coen, G
    Ballanti, P
    Balducci, A
    Calabria, S
    Fischer, MS
    Jankovic, L
    Manni, M
    Morosetti, M
    Moscaritolo, E
    Sardella, D
    Bonucci, E
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) : 233 - 238
  • [7] DESOI CA, 1993, J AM SOC NEPHROL, V4, P1214
  • [8] Renal osteodystrophy:: management of hyperphosphataemia
    Drüeke, TB
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 32 - 33
  • [9] Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism
    Frick, KK
    Bushinsky, DA
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (07) : 1317 - 1325
  • [10] Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients
    Haas, M
    Leko-Mohr, Z
    Roschger, P
    Kletzmayr, J
    Schwarz, C
    Domenig, C
    Zsontsich, T
    Klaushofer, K
    Delling, G
    Oberbauer, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) : 580 - 586